Abstract
SARS-CoV-2 vaccines must be one step ahead of the rapid evolution of the virus. Therefore immunogenic and flexible vaccine platforms are needed. Variants of concern (VOCs) that continually emerge with an unprecedented spread of the virus have already significantly increased the transmissibility and severity of COVID-19 and affected the efficacy and effectiveness of vaccines and vaccinatio…